Princeton, NJ (February 26, 2021) – Verus LLC, a litigation support service firm, has introduced a suite of Claims Processing Services dedicated exclusively to helping plaintiff’s counsel in the Zantac® Census Plus MDL.
“Verus’ new suite of Claims Processing Services designed to handle claims in the Zantac mass tort will help plaintiff’s counsel better focus on the specific details of the actual litigation by quickly identifying non-compensable claims and reducing any rework on compensable claims,” explained Verus Co-Founder and CEO Mark Eveland.
Specially, Verus’ claims processing services for those plaintiff firms representing claimants in the Zantac case include:
“Verus can play a key role helping to identify non-viable cases so that attorneys can fine tune their case criteria early on in the process and save valuable attorney and paralegal resources that would have been otherwise spent on non-viable cases,” noted Dan Comunale, Director of Business Development.
In addition to the claims processing services, Verus also provides:
Zantac has been on the market since the 1980s – in both prescription and over-the-counter formulations. The OTC version is used to treat heartburn and acid indigestion. In its prescription form, it treats ulcers, gastroesophageal reflux disease, and erosive esophagitis. In April 2020, the FDA announced that Zantac contained traces of N-nitrosodimethylamine (NDMA), a chemical impurity that has potential to cause cancer in consumers. The levels of NDMA found in Zantac were declared unacceptable because of NDMA’s health risk. Boehringer Ingelheim Pharmaceuticals, GlaxoSmithKline LLC, Pfrizer Inc, Sanofi-Aventis U.S. LLC, Sanofi US Services Inc., and Chattem Inc. are the named defendants in the pending multi district litigation.
Headquartered in Princeton, NJ, Verus LLC is a litigation support service firm that provides a full suite of services, including Case Management & Medical Review Services, Settlement Administration, Business & Advisory Services, and Analytics Services, to mass tort lawyers. Before founding Verus in 2003, the firm’s principals helped design some of the first-ever mass tort settlements and in the process, administered more than 450,000 asbestos personal injury claims and disbursed more than $6 billion in settlement funds and expenses. Since 2003, Verus has administered over five million personal injury claims and disbursed billions more in settlement funds. Today, Verus is fully engaged in providing litigation support services to law firms working on mass torts. The experts who work at Verus have years of experience in handling cases involving defective medical devices including IVC filters, hernia mesh and transvaginal mesh, and dangerous drugs, including Invokana, Taxotere, PPIs, Xarelto, Benicar and Zofran.
Verus employs over 100 U.S.-based attorneys, nurses, accountants, statisticians and claims adjusters, operations experts, and hardware and software engineers to help mass tort attorneys improve operating results and maximize recoveries for their clients. For more information, visit www.verusllc.com or contact them at firstname.lastname@example.org.
Nina Dietrich, L.L.C.
Nina Dietrich, 201-493-8944